{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:25:28Z","timestamp":1740144328867,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Japan Society Promotion of Science Grant-in-Aid for Scientific Research","award":["JP18K10838"],"award-info":[{"award-number":["JP18K10838"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Physiol Anthropol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Circulating fatty acid-binding protein 4 (FABP4) is a marker for various diseases. It would be highly useful to have simple and less invasive techniques for the assessment of FABP4 concentrations in the clinical research setting. The purpose of the present study was to assess the concordance of circulating FABP4 concentrations in venous and capillary blood both at rest and immediately\u00a0after acute exercise in healthy young males.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Thirty-eight healthy young male adults aged from 19 to 25\u2009years (mean age, 20.8 \u00b1 1.2\u2009years) were recruited. Paired blood samples were taken from the cubital vein (venous) and fingertip (capillary) blood at rest (resting state) and immediately\u00a0after incremental exercise (exercising state). Blood samples were analyzed to determine the circulating FABP4 concentration using an enzyme-linked immunosorbent assay. Pearson\u2019s correlation coefficients for circulating FABP4 concentrations between venous and capillary blood samples indicated a strong positive correlation in both the resting and exercising state (resting state: <jats:italic>r<\/jats:italic> = 0.982, exercising state: <jats:italic>r<\/jats:italic> = 0.989, both <jats:italic>p<\/jats:italic> &lt;\u20090.001). The mean FABP4 concentration was similar between venous and capillary blood in the resting state (<jats:italic>p<\/jats:italic> = 0.178), whereas it was significantly higher in capillary blood than in venous blood in the exercising state (<jats:italic>p<\/jats:italic> &lt;\u20090.001). Furthermore, Bland\u2013Altman plots showed a non-significant bias (\u2212\u20090.07 \u00b1 0.61\u2009ng\/mL, <jats:italic>p<\/jats:italic> = 0.453) in the resting state, whereas a significant bias (\u2212\u20090.45 \u00b1 0.61\u2009ng\/mL, <jats:italic>p<\/jats:italic> &lt;\u20090.001) was observed in the exercising state.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These results indicate that capillary blood sampling can slightly overestimate circulating FABP4 concentrations under a physiologically dynamic state. However, the association between the venous and capillary blood in terms of FABP4 concentration was very strong, suggesting that capillary blood sampling can detect changes in FABP4 concentration in both physiologically steady and dynamic states.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40101-021-00255-z","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T19:57:57Z","timestamp":1612987077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Differences in circulating fatty acid-binding protein 4 concentration in the venous and capillary blood immediately after acute exercise"],"prefix":"10.1186","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0054-692X","authenticated-orcid":false,"given":"Shigeharu","family":"Numao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kurosaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Nakagaichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,10]]},"reference":[{"issue":"Suppl 3","key":"255_CR1","first-page":"23","volume":"8","author":"M Furuhashi","year":"2014","unstructured":"Furuhashi M, Saitoh S, Shimamoto K, Miura T. Fatty acid-binding protein 4 (FABP4): pathophysiological insights and potent clinical biomarker of metabolic and cardiovascular diseases. Clin Med Insights Cardiol. 2014;8(Suppl 3):23\u201333.","journal-title":"Clin Med Insights Cardiol"},{"issue":"22","key":"255_CR2","doi-asserted-by":"publisher","first-page":"8683","DOI":"10.1021\/bi00448a003","volume":"28","author":"CA Baxa","year":"1989","unstructured":"Baxa CA, Sha RS, Buelt MK, Smith AJ, Matarese V, Chinander LL, et al. Human adipocyte lipid-binding protein: purification of the protein and cloning of its complementary DNA. Biochemistry. 1989;28(22):8683\u201390.","journal-title":"Biochemistry"},{"issue":"11","key":"255_CR3","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1073\/pnas.83.11.3786","volume":"83","author":"CR Hunt","year":"1986","unstructured":"Hunt CR, Ro JH, Dobson DE, Min HY, Spiegelman BM. Adipocyte P2 gene: developmental expression and homology of 5'-flanking sequences among fat cell-specific genes. Proc Natl Acad Sci U S A. 1986;83(11):3786\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"255_CR4","doi-asserted-by":"publisher","first-page":"10083","DOI":"10.1016\/S0021-9258(17)44608-4","volume":"258","author":"BM Spiegelman","year":"1983","unstructured":"Spiegelman BM, Frank M, Green H. Molecular cloning of mRNA from 3\u2009T3 adipocytes. Regulation of mRNA content for glycerophosphate dehydrogenase and other differentiation-dependent proteins during adipocyte development. J Biol Chem. 1983;258(16):10083\u20139.","journal-title":"J Biol Chem"},{"issue":"5","key":"255_CR5","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.cmet.2013.04.012","volume":"17","author":"H Cao","year":"2013","unstructured":"Cao H, Sekiya M, Ertunc ME, Burak MF, Mayers JR, White A, et al. Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production. Cell Metab. 2013;17(5):768\u201378.","journal-title":"Cell Metab"},{"issue":"2","key":"255_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/oby.20954","volume":"23","author":"T Mita","year":"2015","unstructured":"Mita T, Furuhashi M, Hiramitsu S, Ishii J, Hoshina K, Ishimura S, et al. FABP4 is secreted from adipocytes by adenyl cyclase-PKA- and guanylyl cyclase-PKG-dependent lipolytic mechanisms. Obesity (Silver Spring). 2015;23(2):359\u201367.","journal-title":"Obesity (Silver Spring)"},{"issue":"4","key":"255_CR7","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1253\/circj.CJ-17-1295","volume":"82","author":"M Furuhashi","year":"2018","unstructured":"Furuhashi M, Yuda S, Muranaka A, Kawamukai M, Matsumoto M, Tanaka M, et al. Circulating fatty acid-binding protein 4 concentration predicts the progression of carotid atherosclerosis in a general population without medication. Circ J. 2018;82(4):1121\u20139.","journal-title":"Circ J"},{"issue":"8","key":"255_CR8","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1161\/ATVBAHA.107.146274","volume":"27","author":"DC Yeung","year":"2007","unstructured":"Yeung DC, Xu A, Cheung CW, Wat NM, Yau MH, Fong CH, et al. Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27(8):1796\u2013802.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"255_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1373\/clinchem.2005.062463","volume":"52","author":"A Xu","year":"2006","unstructured":"Xu A, Wang Y, Xu JY, Stejskal D, Tam S, Zhang J, et al. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem. 2006;52(3):405\u201313.","journal-title":"Clin Chem"},{"issue":"1","key":"255_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.33549\/physiolres.931371","volume":"58","author":"MM Haluzik","year":"2009","unstructured":"Haluzik MM, Anderlova K, Dolezalova R, Adamikova A, Haluzikova D, Housova J, et al. Serum adipocyte fatty acid binding protein levels in patients with type 2 diabetes mellitus and obesity: the influence of fenofibrate treatment. Physiol Res. 2009;58(1):93\u20139.","journal-title":"Physiol Res"},{"issue":"10","key":"255_CR11","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/ajh.2012.88","volume":"25","author":"H Ota","year":"2012","unstructured":"Ota H, Furuhashi M, Ishimura S, Koyama M, Okazaki Y, Mita T, et al. Elevation of fatty acid-binding protein 4 is predisposed by family history of hypertension and contributes to blood pressure elevation. Am J Hypertens. 2012;25(10):1124\u201330.","journal-title":"Am J Hypertens"},{"issue":"2","key":"255_CR12","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.amjcard.2016.04.037","volume":"118","author":"M Furuhashi","year":"2016","unstructured":"Furuhashi M, Omori A, Matsumoto M, Kataoka Y, Tanaka M, Moniwa N, et al. Independent link between levels of proprotein convertase subtilisin\/kexin type 9 and FABP4 in a general population without medication. Am J Cardiol. 2016;118(2):198\u2013203.","journal-title":"Am J Cardiol"},{"issue":"9","key":"255_CR13","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1161\/ATVBAHA.112.248609","volume":"32","author":"M von Eynatten","year":"2012","unstructured":"von Eynatten M, Breitling LP, Roos M, Baumann M, Rothenbacher D, Brenner H. Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study. Arterioscler Thromb Vasc Biol. 2012;32(9):2327\u201335.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"255_CR14","doi-asserted-by":"publisher","first-page":"e004176","DOI":"10.1161\/JAHA.112.004176","volume":"2","author":"WS Chow","year":"2013","unstructured":"Chow WS, Tso AW, Xu A, Yuen MM, Fong CH, Lam TH, et al. Elevated circulating adipocyte-fatty acid binding protein levels predict incident cardiovascular events in a community-based cohort: a 12-year prospective study. J Am Heart Assoc. 2013;2(1):e004176.","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"255_CR15","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1634\/theoncologist.2016-0483","volume":"22","author":"S Guaita-Esteruelas","year":"2017","unstructured":"Guaita-Esteruelas S, Saavedra-Garcia P, Bosquet A, Borras J, Girona J, Amiliano K, et al. Adipose-derived fatty acid-binding proteins plasma concentrations are increased in breast cancer patients. Oncologist. 2017;22(11):1309\u201315.","journal-title":"Oncologist"},{"key":"255_CR16","doi-asserted-by":"crossref","unstructured":"Maekawa M, Ohnishi T, Toyoshima M, Shimamoto-Mitsuyama C, Hamazaki K, Balan S, Wada Y, Esaki K, Takagai S, Tsuchiya KJ, Nakamura K, Iwata Y, Nara T, Iwayama T, Toyota T, Nozaki Y, Ohba H, Watanabe A, Hisano Y, Matsuoka S, Tsujii M, Mori N, Matsuzaki H, Yoshikawa T. A potential role of fatty acid binding protein 4 in the pathophysiology of autism spectrum disorder. Brain Commun. 2020;2(2):fcaa145.","DOI":"10.1093\/braincomms\/fcaa145"},{"issue":"2","key":"255_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3233\/CH-2010-1372","volume":"47","author":"MJ Simmonds","year":"2011","unstructured":"Simmonds MJ, Baskurt OK, Meiselman HJ, Marshall-Gradisnik SM. A comparison of capillary and venous blood sampling methods for the use in haemorheology studies. Clin Hemorheol Microcirc. 2011;47(2):111\u20139.","journal-title":"Clin Hemorheol Microcirc"},{"issue":"1-2","key":"255_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jim.2011.07.008","volume":"372","author":"N Sitoe","year":"2011","unstructured":"Sitoe N, Luecke E, Tembe N, Matavele R, Cumbane V, Macassa E, et al. Absolute and percent CD4+ T-cell enumeration by flow cytometry using capillary blood. J Immunol Methods. 2011;372(1-2):1\u20136.","journal-title":"J Immunol Methods"},{"issue":"12","key":"255_CR19","doi-asserted-by":"publisher","first-page":"e0226374","DOI":"10.1371\/journal.pone.0226374","volume":"14","author":"S Numao","year":"2019","unstructured":"Numao S, Nagasawa Y, Goromaru N, Tamaki S. Comparison of plasma fatty acid binding protein 4 concentration in venous and capillary blood. PLoS One. 2019;14(12):e0226374.","journal-title":"PLoS One"},{"issue":"16-17","key":"255_CR20","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.clinbiochem.2017.05.021","volume":"50","author":"T Iso","year":"2017","unstructured":"Iso T, Sunaga H, Matsui H, Kasama S, Oshima N, Haruyama H, et al. Serum levels of fatty acid binding protein 4 and fat metabolic markers in relation to catecholamines following exercise. Clin Biochem. 2017;50(16-17):896\u2013902.","journal-title":"Clin Biochem"},{"issue":"8982","key":"255_CR21","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(95)91748-9","volume":"346","author":"JM Bland","year":"1995","unstructured":"Bland JM, Altman DG. Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet. 1995;346(8982):1085\u20137.","journal-title":"Lancet"},{"issue":"11","key":"255_CR22","doi-asserted-by":"publisher","first-page":"e81318","DOI":"10.1371\/journal.pone.0081318","volume":"8","author":"S Ishimura","year":"2013","unstructured":"Ishimura S, Furuhashi M, Watanabe Y, Hoshina K, Fuseya T, Mita T, et al. Circulating levels of fatty acid-binding protein family and metabolic phenotype in the general population. PLoS One. 2013;8(11):e81318.","journal-title":"PLoS One"},{"issue":"10","key":"255_CR23","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1089\/dia.2009.0023","volume":"11","author":"K Kempe","year":"2009","unstructured":"Kempe K, Price D, Ellison J, Marhoul J, Morrow L, Win K, et al. Capillary and venous blood glucose concentrations measured during intravenous insulin and glucose infusion: a comparison of steady and dynamic states. Diabetes Technol Ther. 2009;11(10):669\u201374.","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"255_CR24","first-page":"39","volume":"38","author":"J Dassonville","year":"1998","unstructured":"Dassonville J, Beillot J, Lessard Y, Jan J, Andre AM, Le Pourcelet C, et al. Blood lactate concentrations during exercise: effect of sampling site and exercise mode. J Sports Med Phys Fitness. 1998;38(1):39\u201346.","journal-title":"J Sports Med Phys Fitness"},{"issue":"3","key":"255_CR25","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1123\/ijsnem.13.3.358","volume":"13","author":"DA Rubin","year":"2003","unstructured":"Rubin DA, McMurray RG, Harrell JS, Carlson BW, Bangdiwala S. Accuracy of three dry-chemistry methods for lipid profiling and risk factor classification. Int J Sport Nutr Exerc Metab. 2003;13(3):358\u201368.","journal-title":"Int J Sport Nutr Exerc Metab"},{"issue":"Pt 2","key":"255_CR26","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1177\/000456328802500208","volume":"25","author":"HC Seftel","year":"1988","unstructured":"Seftel HC, Panz VR, Baker SG, Joffe BI, Mendelsohn D. Determination of cholesterol and triglycerides in blood: a comparison between wet chemistry methods and a dry chemistry analyser. Ann Clin Biochem. 1988;25(Pt 2):176\u201380.","journal-title":"Ann Clin Biochem"},{"issue":"1","key":"255_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2337\/diacare.27.1.89","volume":"27","author":"N Mohanlal","year":"2004","unstructured":"Mohanlal N, Holman RR. A standardized triglyceride and carbohydrate challenge: the oral triglyceride tolerance test. Diabetes Care. 2004;27(1):89\u201394.","journal-title":"Diabetes Care"},{"issue":"8","key":"255_CR28","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3109\/00365517609081941","volume":"36","author":"U Larsson-Cohn","year":"1976","unstructured":"Larsson-Cohn U. Differences between capillary and venous blood glucose during oral glucose tolerance tests. Scand J Clin Lab Invest. 1976;36(8):805\u20138.","journal-title":"Scand J Clin Lab Invest"},{"issue":"1-2","key":"255_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0009-8981(01)00426-0","volume":"307","author":"K Kuwa","year":"2001","unstructured":"Kuwa K, Nakayama T, Hoshino T, Tominaga M. Relationships of glucose concentrations in capillary whole blood, venous whole blood and venous plasma. Clin Chim Acta. 2001;307(1-2):187\u201392.","journal-title":"Clin Chim Acta"},{"issue":"11","key":"255_CR30","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1046\/j.1464-5491.2003.01048.x","volume":"20","author":"S Colagiuri","year":"2003","unstructured":"Colagiuri S, Sandbaek A, Carstensen B, Christensen J, Glumer C, Lauritzen T, et al. Comparability of venous and capillary glucose measurements in blood. Diabet Med. 2003;20(11):953\u20136.","journal-title":"Diabet Med"},{"issue":"3","key":"255_CR31","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1365-2249.2007.03515.x","volume":"150","author":"M Eriksson","year":"2007","unstructured":"Eriksson M, Sartono E, Martins CL, Bale C, Garly ML, Whittle H, et al. A comparison of ex vivo cytokine production in venous and capillary blood. Clin Exp Immunol. 2007;150(3):469\u201376.","journal-title":"Clin Exp Immunol"},{"issue":"3-4","key":"255_CR32","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/BF00357603","volume":"61","author":"P Foxdal","year":"1990","unstructured":"Foxdal P, Sjodin B, Rudstam H, Ostman C, Ostman B, Hedenstierna GC. Lactate concentration differences in plasma, whole blood, capillary finger blood and erythrocytes during submaximal graded exercise in humans. Eur J Appl Physiol Occup Physiol. 1990;61(3-4):218\u201322.","journal-title":"Eur J Appl Physiol Occup Physiol"},{"issue":"4","key":"255_CR33","first-page":"261","volume":"36","author":"JA Flohr","year":"1996","unstructured":"Flohr JA, Womack CJ, Kovalcik PC. Comparison of capillary and venous blood lactate and glucose values during cycle ergometry. J Sports Med Phys Fitness. 1996;36(4):261\u20134.","journal-title":"J Sports Med Phys Fitness"},{"issue":"2","key":"255_CR34","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.cyto.2014.10.011","volume":"71","author":"T Cullen","year":"2015","unstructured":"Cullen T, Thomas AW, Webb R, Hughes MG. The relationship between interleukin-6 in saliva, venous and capillary plasma, at rest and in response to exercise. Cytokine. 2015;71(2):397\u2013400.","journal-title":"Cytokine"}],"container-title":["Journal of Physiological Anthropology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40101-021-00255-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40101-021-00255-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40101-021-00255-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T20:00:05Z","timestamp":1612987205000},"score":1,"resource":{"primary":{"URL":"https:\/\/jphysiolanthropol.biomedcentral.com\/articles\/10.1186\/s40101-021-00255-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,10]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["255"],"URL":"https:\/\/doi.org\/10.1186\/s40101-021-00255-z","relation":{},"ISSN":["1880-6805"],"issn-type":[{"type":"electronic","value":"1880-6805"}],"subject":[],"published":{"date-parts":[[2021,2,10]]},"assertion":[{"value":"21 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We ensure that this work has been carried out in accordance with the Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans, and informed consent was obtained from all participants. The study protocol was approved by the Ethics Committee of the National Institute of Fitness and Sports in Kanoya.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This is not applicable as the study does not have individual person\u2019s data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}